Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
The Korean Journal of Internal Medicine
|
January 11, 2022
The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction
Keun-Ho Park, Myung Ho Jeong, Hyun Kuk Kim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 30, 2008
Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention
Hae Chang Jeong, Young Keun Ahn, Myung Ho Jeong, et al.
Clinical Therapeutics
|
April 9, 2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension
Hae-Young Lee, Yong-Jin Kim, Taehoon Ahn, et al.
The American Journal of Cardiology
|
September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
The American Journal of Cardiology
|
September 25, 2019
Comparison of Two-Year Outcomes of Acute Myocardial Infarction Caused by Coronary Artery Spasm Versus that Caused by Coronary Atherosclerosis
Ju Yeol Baek, Byoung Geol Choi, Seung-Woon Rha, et al.
Journal of Korean Medical Science
|
November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study
Ung Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
JACC. Cardiovascular Interventions
|
May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation
Youngjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Korean Circulation Journal
|
June 6, 2019
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease
Keun Ho Park, Youngkeun Ahn, Young Youp Koh, et al.
Coronary Artery Disease
|
February 2, 2019
Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry
Sung Gyun Ahn, Jun-Won Lee, Dae Ryong Kang, et al.
JACC. Asia
|
April 1, 2026
Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease
Chang Hoon Kim, Hyun Sung Joh, Hyun Kuk Kim, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
The Korean Journal of Internal Medicine
|
January 11, 2022
The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction
Keun-Ho Park, Myung Ho Jeong, Hyun Kuk Kim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 30, 2008
Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention
Hae Chang Jeong, Young Keun Ahn, Myung Ho Jeong, et al.
Clinical Therapeutics
|
April 9, 2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension
Hae-Young Lee, Yong-Jin Kim, Taehoon Ahn, et al.
The American Journal of Cardiology
|
September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
The American Journal of Cardiology
|
September 25, 2019
Comparison of Two-Year Outcomes of Acute Myocardial Infarction Caused by Coronary Artery Spasm Versus that Caused by Coronary Atherosclerosis
Ju Yeol Baek, Byoung Geol Choi, Seung-Woon Rha, et al.
Journal of Korean Medical Science
|
November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study
Ung Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
JACC. Cardiovascular Interventions
|
May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation
Youngjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Korean Circulation Journal
|
June 6, 2019
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease
Keun Ho Park, Youngkeun Ahn, Young Youp Koh, et al.
Coronary Artery Disease
|
February 2, 2019
Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry
Sung Gyun Ahn, Jun-Won Lee, Dae Ryong Kang, et al.
JACC. Asia
|
April 1, 2026
Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease
Chang Hoon Kim, Hyun Sung Joh, Hyun Kuk Kim, et al.
Page
of 15